The transmissible respiratory disease COVID-19, caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has affected millions of people worldwide since its …

Introduction Covid‐19 is linked with the development of cardio‐metabolic disorders,
including dyslipidemia, dysregulation of high‐density lipoprotein (HDL), and low‐density …

The current Coronavirus disease 2019 (COVID-19) pandemic has become a global
challenge. Managing a large number of acutely ill patients in a short time, whilst reducing …

There is a close relationship between the SARS-CoV-2 virus and lipoproteins, in particular
high-density lipoprotein (HDL). The severity of the coronavirus disease 2019 (COVID-19) is …

The recently emerged pathogenic SARS-coronavirus 2 (SARS-CoV-2) has spread rapidly,
leading to a global pandemic. In this study, we show that SARS-CoV-2 infection was …

Plasma membrane cholesterol is required for proper trafficking and localization of receptors
that facilitate severe acute respiratory syndrome coronavirus 2 infection. High-density …

COVID-19, caused by the SARS-CoV-2 coronavirus, emerged as a global pandemic in late
2019, resulting in significant global public health challenges. The emerging evidence …

High-density lipoproteins (HDLs) are a class of blood particles, principally involved in
mediating reverse cholesterol transport from peripheral tissue to liver. Omics approaches …

Responsible for the ongoing coronavirus disease 19 (COVID-19) pandemic, severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells through binding of the …

Abstract Coronavirus disease 2019 (COVID-19) pandemic is affecting millions of patients
worldwide. The consequences of initial exposure to SARS-CoV-2 go beyond pulmonary …